Boston Scientific Principal Downstream Product Manager - Capital Software Service 

United States, Massachusetts, Marlborough 

777034296

Your responsibilities will include:

• This includes involvement in developing and implementing marketing initiatives, driving the growth of existing capital and future capital and software/service products globally, and championing global commercial execution to ensure achievement of ambitious growth targets
• You will contribute to the development of the Software and Service roadmap, product planning, and end-to-end product delivery. Influence key commercial stakeholders to build the momentum on service commercialization.
• The ideal candidate will demonstrate strong technical expertise and excel in cross-functional collaboration and project management,
• Independently develop, key global business planning activities and ensure accuracy and conformity in forecasting and supply chain, operations and budget management.
• Works closely with upstream counterpart, R&D and business teams to ensure that prioritized programs have the necessary dedicated resources for execution
• Support Sales training related to capital and service programs to enable successful interaction with non-MD hospital customers - IT, Biomed and Administrators.
• Influence upstream projects and launch cadence, providing guidance/direction for TDP/PDP and advisory board concept, organization, and execution; represent franchise projects and interests at PIB and TRB meetings, and assist in preparing and presenting at business planning team meetings.
• Contribute to setting market development and planning priorities.
• Develops global relationships and builds credibility/influence with internal cross-functional stakeholders across multiple countries/regions
• Contribute to franchise global downstream marketing and sales, and suggest means to improve strategy and effectiveness.
• Contribute to understanding key industry dynamics and trends and in formulating strategy and concept messaging techniques.
• Network with colleagues in other franchises and cross-functional departments to enhance own franchise systems and processes to accomplish “best in class” business objectives.
• Demonstrates a primary commitment to patient safety and product quality. Understands and complies with all regulations governing the quality systems.

Required Qualifications:

• 7+ years of medical device capital equipment experience required.
• 2+ years experience of commercializing capital and service programs.
• Experience of managing and engaging hospital IT and Biomed team
• Product launch experience is required
• BA/BS required, Master’s/MBA preferred
• 5 years experience in - Downstream (product launch/commercialization)
• Experience in GI Endoscopy and/or Surgery space is plus
• Knowledge in capital integration and PACs connectivity is plus
• Medical device sales experience preferred
• Demonstrated success working as an integral cross functional team member, and ability to develop deep clinical expertise in medical device product line.
• Demonstrated success supporting and/or managing complex projects related to capital
• Ability to collaborate and work with others in a dynamic, matrix environment
• Position requires ~40% travel (international included)
• Excellent communication and interpersonal skills
  

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.